22 results on '"Franchino-Elder, Jessica"'
Search Results
2. Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease
3. Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study
4. Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers
5. Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial
6. Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy
7. Comparison of healthcare costs among patients with non‐valvular atrial fibrillation treated with warfarin who switched to a novel oral anticoagulant
8. Detecting schizophrenia early: Prediagnosis healthcare utilization characteristics of patients with schizophrenia may aid early detection
9. Healthcare resource utilization and expenditures among newly-diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants
10. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis
11. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis
12. Healthcare Resource Utilization among Non-Valvular Atrial Fibrillation Patients Who Switched from Warfarin to a Novel Oral Anti-Coagulant
13. Abstract 283: Healthcare Resource Utilization and Costs Associated with Oral Anticoagulant Reversal Therapy
14. HEALTH CARE RESOURCE UTILIZATION AND EXPENDITURES AMONG NEWLY DIAGNOSED NON-VALVULAR ATRIAL FIBRILLATION PATIENTS INITIATING ORAL ANTI-COAGULANTS: RESULTS FROM 100% MEDICARE 2010-2015 DATA
15. Abstract WP400: Healthcare Utilization (HCRU) Among Non-Valvular Atrial Fibrillation (NVAF) Patients Who Switched From Warfarin to an Novel Oral Anti-Coagulant (NOAC)
16. Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin
17. Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population
18. F214. Health Care Resource Utilization is Higher in Patients Prior to Diagnosis With Schizophrenia Than Non-Schizophrenia Comparators in a Large Commercially Insured Population in the United States
19. Abstract 277: Comparison of All-Cause Hospitalization Rates and 30-Day Readmissions Among Patients With Non-Valvular Atrial Fibrillation, Newly Diagnosed and Newly Treated With Dabigatran, Rivaroxaban or Warfarin
20. S252. HEALTH CARE RESOURCE UTILISATION IS HIGHER IN PATIENTS PRIOR TO DIAGNOSIS WITH SCHIZOPHRENIA THAN NON-SCHIZOPHRENIA COMPARATORS IN A LARGE COMMERCIALLY-INSURED POPULATION IN THE UNITED STATES
21. Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants
22. 4.47 Patient Characteristics and Patterns of Care Prior to Schizophrenia Diagnosis in a Large Commercially-Insured Population of Adolescents and Young Adults in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.